acarbose, a novel drug for type II, or non-insulin-dependent, diabetes

Bayer is now launching acarbose, a novel drug for type II, or non-insulin-dependent, diabetes. ...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login